The Europe Hydrogel-based Drug Delivery System Market is expected to witness market growth of 7.6% CAGR during the forecast period (2021-2027).
Hydrogel-based drug delivery systems provide the therapeutic drug straight to the required site and in a sustainable manner. It can give beneficial results like minimize side effects, enhanced efficacy, and reduced dosage for patients & formulators. These hydrogel-based drug delivery systems are attracting several medical companies and have been utilized in numerous branches of medicine like pain management, oncology, cardiology, immunology, and wound management.
The growing prevalence of several diseases like CNS disorders is accelerating the demand for various therapies and thus, creating more demand for the hydrogel-based drug delivery systems in the European region. In addition, several companies are significantly investing in R&D to find out different medicines and treatments for different types of diseases.
Certain market players are majorly focusing on the optimization of hydrogel-based protein delivery, which is expected to attract more customers towards it and hence, boosting the growth of the hydrogel-based drug delivery system market during the forecast period. The increasing investment of the authorities on various medical projects is surging the growth of the hydrogel-based drug delivery system market in the European region.
The Germany market dominated the Europe Oral Cavity Market by Country in 2020, thereby, achieving a market value of $83.7 Million by 2027. The UK market is exhibiting a CAGR of 6.8% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 8.1% during (2021 - 2027).
Based on Polymer Origin, the market is segmented into Synthetic, Natural and Hybrid. Based on Delivery Route, the market is segmented into Ocular, Subcutaneous, Oral Cavity, Topical and Other Delivery Routes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Bausch Health Companies, Inc., Medtronic PLC, Galderma S.A., Endo International PLC, Ferring Holdings SA, Akorn Operating Company LLC, Tolmar Pharmaceuticals, Inc., Blairex Laboratories, Inc., and Ocular Therapeutix, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Polymer Origin
- Synthetic
- Natural
- Hybrid
By Delivery Route
- Ocular
- Subcutaneous
- Oral Cavity
- Topical
- Other Delivery Routes
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- Bausch Health Companies, Inc.
- Medtronic PLC
- Galderma S.A.
- Endo International PLC
- Ferring Holdings SA
- Akorn Operating Company LLC
- Tolmar Pharmaceuticals, Inc.
- Blairex Laboratories, Inc.
- Ocular Therapeutix, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Johnson & Johnson
- Bausch Health Companies, Inc.
- Medtronic PLC
- Galderma S.A.
- Endo International PLC
- Ferring Holdings SA
- Akorn Operating Company LLC
- Tolmar Pharmaceuticals, Inc.
- Blairex Laboratories, Inc.
- Ocular Therapeutix, Inc.
Methodology
LOADING...
